Scientia Advisors - Science, knowledge and skill for your competitive advantage

Archive for August, 2011

Via Oncology and Other Pathways Programs Are Influencing the Patient Care Paradigm

Posted by: Jonathan Pan on August 23, 2011 | No Comments »
Related to: Healthcare Trends

Administration of care is changing as evidenced by previous blog posts from my colleagues. Many of these changes are not only coming from new therapeutic products, but from the actual coordination of care and the choices of therapy. Physicians are now able to make decisions with the full backing of evidence-based medicine. These decisions are beginning to bring to light new paradigm shifts, particularly in cancer care, where the introduction of palliative therapy and hospice are becoming more prevalent. To investigate how some of these shifts are occurring, I recently chatted with Ed Rodgers, Pathways Subject Matter Expert at Via Oncology which offers a decision support tool that is impacting the patient care paradigm.

Continue reading »


Comparison of Antipsychotics for Metabolic Problems (CAMP) Trial: Do the Results Provide New Leverage for a Marketing Strategy for Abilify?

Posted by: Jeff Stoll on August 18, 2011 | No Comments »
Related to: Therapeutics

Various drug manufacturers of second generation atypical antipsychotics (SGAs) have been anticipating the results of the Comparison of Antipsychotics for Metabolic Problems (otherwise known as CAMP) trial. The publication of the CAMP trial results was potentially a key market event for the promoters of Abilify (aripiprazole). At the time of the CAMP trial’s conception, the link between SGA and metabolic side effects was becoming a hotly debated topic.

Four years ago, when the CAMP trial began recruiting its first patients, demonstrating the benefit of switching patients from an SGA with more metabolic side effects to one with fewer metabolic side effects appeared to be an important research endeavor and marketing strategy. Science, however, is rarely stagnant: it is four years later, and a vital question BMS and Otsuka must answer is, are the newly released results from CAMP meaningful given the current market conditions and scientific progress?

Continue reading »


Mobile Health in 2011: The Revolution Begins

Posted by: Joe McWilliams on August 9, 2011 | 3 Comments »
Related to: Healthcare Trends

One of the most fascinating “Blue Ocean” spaces for companies exploring opportunities in healthcare is in mobile health (mHealth). This is a high-growth market sector that uses mobile technologies and consumer applications to increase efficiencies in healthcare delivery. For the US healthcare system, which is in desperate need of innovation and cost-saving approaches, we believe that mobile health has much to offer.

What’s Really Driving the Furious Pace of Changes in Healthcare Delivery

Mobile health markets are propelled by a number of key drivers:

Continue reading »


Mind the Gap: Clinical Needs vs. Scientific Focus

Posted by: Margaret Liao on August 4, 2011 | No Comments »
Related to: Healthcare Trends, In Vitro Diagnostics

Deductive reasoning lays the foundation of science, enabling hypotheses to be tested and theories to be proven. However, while X may lead to Y in a particular situation, the same logic cannot be applied universally. Take the clinical world; would you expect a similar methodological approach to result in each unmet need being addressed with appropriate attention and resources? Mr. Stan Lapidus, a renowned entrepreneur who founded multiple million-dollar life science companies, shed some light on this topic at a recent Scientia Luminary Session, where leading experts from the healthcare industry come and share their insights with the Scientia team. Through Mr. Lapidus’ Q&A session, it can be inferred that though deductive reasoning is often used to verify research studies, the same logic does not define how the medical world operates. What is clinically important, he argued, may often still be overlooked due to a lack of attention and resources. This is the reason why so many clinical needs remain unresolved and opportunities for entrepreneurs exist.

Continue reading »


Subscribe via RSS »

Receive Posts via Email »



Browse Categories


About Scientia’s Blog

Scientia Advisors Blog offers strategic insights on the latest in the health care, life science and biotech industries. It is a company blog to which many Scientia team members contribute.


Archives

May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010


SCIENTIA ADVISORS, LLC  |  info@scientiaadv.com


55 Cambridge Parkway, Suite 300E, Cambridge MA 02142  |  Phone: 617-299-3000  |  Fax: 617-812-0315

© 2012 Scientia Advisors LLC